Recent Updates
Recently added Catalysts
ENVB Positive Sentiment Score: 75/100

Psychedelic Nation? Psilocybin Treatments Offer New Hope for People Prozac Hasn’t Helped [The Daily Upside]

Sunday, July 5, 2026 1 min read
Key Takeaway: The article discusses the growing interest in psilocybin treatments for mental health, highlighting endorsements from notable figures like OpenAI CEO Sam Altman. It suggests that such psychedelic experiences may offer hope for individuals who have not found relief with conventional medications like Prozac. The trend is gaining traction among tech innovators and the broader public.
Price reaction · baseline $1.45 (2026-07-02 close) · clean, no other ENVB news in the window
day 0 close · peak
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Psychedelic treatments like psilocybin show promise for mental health.
  • High-profile endorsements from influential figures boost credibility.
  • Potential alternative for those unresponsive to traditional medications.

Full Press Release Details

OpenAI CEO Sam Altman, once a “very anxious, unhappy person,” credits a psychedelic experience at a weekend-long retreat with helping him become a new man. He’s not unique among Silicon Valley luminaries: Some of the 21st century’s most famous tech innovators, from Steve Jobs to Elon Musk and Sergey Brin, have reportedly sought out such experiences, too (on the record, or otherwise).
Full Article >>

Frequently Asked Questions

What is psilocybin?

Psilocybin is a naturally occurring psychedelic compound found in certain mushrooms.

How does psilocybin help with mental health?

Psilocybin treatments may provide relief for individuals who have not responded to traditional medications.

Who has endorsed psilocybin treatments?

Notable figures like OpenAI CEO Sam Altman and other tech innovators have endorsed psilocybin.

What traditional medication is mentioned in the article?

Prozac is mentioned as a common medication that some individuals do not find effective.

Tags: ENVB Viatris Investor Conferences Healthcare psilocybin mental health prozac psychedelics
Last updated: Jul 5, 2026

Biotech snapshot

Cash runway
$5M liquidity · $1M/mo burn
~4 mo
High dilution risk